Literature DB >> 22918652

[Fluid management - which fluid for what type of patients?].

Matthias Heringlake1, Hermann Heinze, Kirk Brauer.   

Abstract

There is a renewed discussion about the role of crystalloids and natural as well as synthetic colloids in fluid resuscitation. Based on the currently available evidence the choice of fluid replacement does not influence mortality. However, there is increasing evidence that due to unwarranted organ effects of the specific replacement fluids, individual subgroups of patients may be preferentially treated either with cristalloids or colloids. © Georg Thieme Verlag Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22918652     DOI: 10.1055/s-0032-1323570

Source DB:  PubMed          Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther        ISSN: 0939-2661            Impact factor:   0.698


  2 in total

1.  PragmaTic, prospEctive, randomized, controlled, double-blind, mulTi-centre, multinational study on the safety and efficacy of a 6% HydroxYethyl Starch (HES) solution versus an electrolyte solution in trauma patients: study protocol for the TETHYS study.

Authors:  Clementina Duran Palma; Musawenkosi Mamba; Johan Geldenhuys; Oluwafolajimi Fadahun; Rolf Rossaint; Kai Zacharowski; Martin Brand; Óscar Díaz-Cambronero; Javier Belda; Martin Westphal; Ute Brauer; Dirk Dormann; Tamara Dehnhardt; Martin Hernandez-Gonzalez; Sonja Schmier; Dianne de Korte; Frank Plani; Wolfgang Buhre
Journal:  Trials       Date:  2022-06-02       Impact factor: 2.728

2.  Prospective, randomized, controlled, double-blind, multi-center, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) sOlution versus an Electrolyte solutioN In patients undergoing eleCtive abdominal Surgery: study protocol for the PHOENICS study.

Authors:  Wolfgang Buhre; Dianne de Korte-de Boer; Marcelo Gama de Abreu; Thomas Scheeren; Matthias Gruenewald; Andreas Hoeft; Donat R Spahn; Alexander Zarbock; Sylvia Daamen; Martin Westphal; Ute Brauer; Tamara Dehnhardt; Sonja Schmier; Jean-Francois Baron; Stefan De Hert; Željka Gavranović; Bernard Cholley; Tomas Vymazal; Wojciech Szczeklik; Helmar Bornemann-Cimenti; Marina Blanca Soro Domingo; Ioana Grintescu; Radmilo Jankovic; Javier Belda
Journal:  Trials       Date:  2022-02-22       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.